Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients

被引：0
|
作者：
Andreana De Mauri
Matteo Vidali
Doriana Chiarinotti
Giorgio Bellomo
Roberta Rolla
机构：
[1] “Maggiore della Carità” University Hospital,Nephrology and Dialysis Unit
[2] Amedeo Avogadro University of Eastern Piedmont,Department of Health Sciences
[3] “Maggiore della Carità” University Hospital,Clinical Chemistry Laboratory
来源：
Journal of Nephrology | 2019年 / 32卷
关键词：
Lipoprotein-associated phospholipase A2; Cardiovascular disease; Hemodialysis; Mortality; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 288
页数：5
相关论文
共 50 条
  • [11] Lipoprotein-associated Phospholipase A2 in Coronary Artery Disease
    Dimitroglou, Yannis
    Sakalidis, Athanasios
    Mavroudis, Andreas
    Kalantzis, Charalambos
    Valatsou, Angeliki
    Andrikou, Ioannis
    Christofi, Angela
    Mantzouranis, Emmanouil
    Kachrimanidis, Ioannis
    Bei, Evellina
    Lazarou, Emilia
    Tsioufis, Costas
    Tousoulis, Dimitris
    Lazaros, George
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2022, 22 (28) : 2344 - 2354
  • [12] Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors
    Acevedo, Monica
    Varleta, Paola
    Kramer, Veronica
    Quiroga, Teresa
    Prieto, Carolina
    Parada, Jacqueline
    Adasme, Marcela
    Briones, Luisa
    Navarrete, Carlos
    REVISTA MEDICA DE CHILE, 2013, 141 (11) : 1382 - 1388
  • [13] Lipoprotein-Associated Phospholipase A2: Relation to Development of Ischemic Stroke in Patients With Essential Hypertension
    Polupanov, A. G.
    Lomteva, J. N.
    Khalmatov, A. N.
    Cheskidova, N. B.
    Romanova, T. A.
    Dzhumagulova, A. S.
    KARDIOLOGIYA, 2014, 54 (06) : 29 - 34
  • [14] Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors
    Chauffe, Ryan J.
    Wilensky, Robert L.
    Mohler, Emile R., III
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (01) : 43 - 47
  • [15] Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection
    Eckard, A. Ross
    Longenecker, C. T.
    Jiang, Y.
    Debanne, S. M.
    Labbato, D.
    Storer, N.
    McComsey, G. A.
    HIV MEDICINE, 2014, 15 (09) : 537 - 546
  • [16] Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis
    Winkler, Karl
    Hoffmann, Michael M.
    Krane, Vera
    Drechsler, Christiane
    Wanner, Christoph
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (07) : 693 - 701
  • [17] Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study
    Fitzpatrick, Annette L.
    Irizarry, Michael C.
    Cushman, Mary
    Jenny, Nancy S.
    Chi, Gloria C.
    Koro, Carol
    ATHEROSCLEROSIS, 2014, 235 (02) : 384 - 391
  • [18] New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease
    Tsimikas, Sotirios
    Tsironis, Loukas D.
    Tselepis, Alexandros D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (10) : 2094 - 2099
  • [19] Clinical Role of Lipoprotein-Associated Phospholipase A2
    Miklishanskaya, S. V.
    Lyakishev, A. A.
    Kukharchuk, V. V.
    KARDIOLOGIYA, 2013, 53 (03) : 59 - 70
  • [20] Lipoprotein-associated phospholipase A2 predicts lower limb ischemia in hemodialysis subjects
    De Mauri, Andreana
    Vidali, Matteo
    Chiarinotti, Doriana
    Dianzani, Umberto
    Rolla, Roberta
    THERAPEUTIC APHERESIS AND DIALYSIS, 2020, 24 (05) : 548 - 553
12345